Featured

Worldwide Mylan EpiPen Recall Includes The U.S.A.

Mylan CEO Heather Bresch testifying on Capitol Hill in September.

You all remember the big pharma company Mylan right…the very same Mylan that raised the price of this very same epipen 500% last year….YES THAT MYLAN….

Worldwide Mylan EpiPen recall extends to US

Published on Apr 1, 2017

Drugmaker Mylan issued the recall in eight countries, including the U.S.

Defective Part Prompts Recall Of 80,000 EpiPens

Published on Mar 21, 2017

Four batches of EpiPens are being recalled because they may fail to activate when used. According to a statement by drug maker Mylan, about 80,000 EpiPen auto-injectors are being recalled worldwide. The recall includes the following batch numbers: 5FA665, 5FA6651, 5FA6652, 5FA6653. To date, there have been two reported cases of the EpiPens failing to work properly. “The failure of the auto-injector to activate may result in patients not receiving the required dose of adrenaline, resulting in the worsening of symptoms.” Mylan-owned Alphapharm said. Those with affected devices should return it to their pharmacist, who will provide a replacement for free.

Mylan is recalling EpiPens in the US

Mylan is recalling EpiPens in the United States.

The voluntary recall comes just 10 days after Mylan issued a recall of more than 80,000 devices from around the world.

“This recall is being conducted as a result of the receipt of two previously disclosed reports outside of the U.S. of failure to activate the device due to a potential defect in a supplier component,” Mylan said in a statement.

“The potential defect could make the device difficult to activate in an emergency (failure to activate or increased force needed to activate) and have significant health consequences for a patient experiencing a life-threatening allergic reaction (anaphylaxis). ”

Mylan said it’s extending the lots included in the recall as a precautionary measure. The devices, manufactured by Meridian Medical Technologies, were made between December 2015 and July 2016.

Mylan was called out in August 2016 for raising the price of the EpiPen to $608.61 from $93.88 over the past decade. It caught the nation’s attention because parents were refilling their kids’ prescriptions, and some found that they were on the hook for hundreds of dollars for the device. The recall doesn’t include the authorized generic version of the EpiPen that Mylan introduced in December.

Mylan said in a release that the EpiPens that are recalled will be replaced at no cost.

Here are the lots impacted by the recall:

Screen Shot 2017 03 31 at 5.26.09 PM

This is exactly what happens when big pharma is allowed, by the government run FDA, to run willy nilly over the entire USA without one damn regulation on pricing or manufacturing.

Kinda sounds like……

Advertisements

Reply At Your Own Risk. Leave The Dumbfuckery At The Door.

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s